Many users experience significant and sustained weight reduction, along with a decreased appetite that makes maintaining healthy choices easier
Typical Weekly Pattern During This Phase Weight loss: 0.5-1 pound weekly on average, with occasional plateau weeks Appetite: Remains suppressed but slightly less dramatically than weeks 13-24 Energy: Stable, though some people report slight decrease from peak energy in weeks 16-24 Side effects: Minimal
No, retatrutide has not yet received marketing authorisation from the MHRA or EMA and remains an investigational medicine
Given these differences, selecting the right GLP-1RA should be based on individual patient needs, including glycemic targets, weight loss goals, tolerability, and preference for dosing frequency
GLP-1 therapies remain expensive, and insurance coverage varies
Always dose first thing, before coffee, before food, before anything except plain water to take other critical medications